APA (7th ed.) Citation

Cheng, R., Boparai, M., Zhu, X., & Wu, S. (2025). Increased Risk of Hyperglycemia in Advanced Urothelial Cancer Patients Treated with Enfortumab Vedotin: A Systematic Review and Meta-Analysis. Cancer Investigation, 43(5), 293. https://doi.org/10.1080/07357907.2025.2502992

Chicago Style (17th ed.) Citation

Cheng, Ryan, Montek Boparai, Xiaolei Zhu, and Shenhong Wu. "Increased Risk of Hyperglycemia in Advanced Urothelial Cancer Patients Treated with Enfortumab Vedotin: A Systematic Review and Meta-Analysis." Cancer Investigation 43, no. 5 (2025): 293. https://doi.org/10.1080/07357907.2025.2502992.

MLA (9th ed.) Citation

Cheng, Ryan, et al. "Increased Risk of Hyperglycemia in Advanced Urothelial Cancer Patients Treated with Enfortumab Vedotin: A Systematic Review and Meta-Analysis." Cancer Investigation, vol. 43, no. 5, 2025, p. 293, https://doi.org/10.1080/07357907.2025.2502992.